CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME
Clinical trials for CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME trials appear
Sign up with your email to follow new studies for CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early trial for young cancer patients halted before starting
Disease control TerminatedThis early-phase study aimed to test the safety and effectiveness of a two-drug immunotherapy combination (nivolumab and ipilimumab) in children, teens, and young adults. It was specifically for patients whose cancers had returned or stopped responding to standard treatments and …
Matched conditions: CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
New hope for kids with aggressive brain cancers: early trial tests immune therapy
Disease control OngoingThis early-stage trial is testing the safety and early effectiveness of a drug called pembrolizumab in children with aggressive brain tumors that have come back or stopped responding to standard treatments. The drug is an immunotherapy, which aims to help the body's own immune sy…
Matched conditions: CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC